Finfgeld, 2002 Selective serotonin reuptake inhibitor. Discontinuation syndrome

[Altostrata]

A 2002 publication for nurses. When will doctors get the message?

 

J Psychosoc Nurs Ment Health Serv. 2002 Dec;40(12):14-8.

Selective serotonin reuptake inhibitor. Discontinuation syndrome.

Finfgeld DL.

 

Source

 

Sinclair School of Nursing, University of Missouri, Columbia, MO 65211, USA. finfgeldD@health.missouri.edu

 

Abstract at http://www.ncbi.nlm.nih.gov/pubmed/12491870. Full text here.

 

Based on emerging research findings, nurses are urged to become more aware of SSRI discontinuation syndrome. To ameliorate or avoid the associated symptoms, client education is recommended, and dosage tapering is encouraged whenever possible. Although the symptoms associated with discontinuation syndrome usually are mild, they may pose particular safety concerns for clients with co-occurring conditions. In these situations, precautions should be taken to prevent exacerbation of existing problems.

[lupe]

J Psychosoc Nurs Ment Health Serv

2002 Dec;40(12):14-8.doi: 10.3928/0279-3695-20021201-10.

 

Selective serotonin reuptake inhibitor. Discontinuation syndrome

Deborah L Finfgeld

 

PMID: 12491870

 

DOI: 10.3928/0279-3695-20021201-10

 

Full text pdf. Hope it can be opened.

20111107091312.pdf

 

Abstract at https://pubmed.ncbi.nlm.nih.gov/12491870/

 

Based on emerging research findings, nurses are urged to become more aware of SSRI discontinuation syndrome. To ameliorate or avoid the associated symptoms, client education is recommended, and dosage tapering is encouraged whenever possible. Although the symptoms associated with discontinuation syndrome usually are mild, they may pose particular safety concerns for clients with co-occurring conditions. In these situations, precautions should be taken to prevent exacerbation of existing problems.

Edited February 13 by Altostrata
put in Journals format

[Altostrata]

Added link to full text up above.